Albumin corona on nanoparticles – a strategic approach in drug delivery

Abstract

Nanomaterials have been used widely for delivery of therapeutic agents. Protein-nanoparticle (NP) complexes have gained importance as vehicles for targeted drug delivery due to increased ease of administration, stability and half-life of drug, and reduced toxic side effects. Designing of phospholipid-bovine serum albumin (BSA) complexes and stealth NPs with BSA has paved the way for drug delivery carriers with prolonged blood circulation times. Preformed albumin corona has shown to decrease non-specific association and thereby reduce the clearance rate. Albumin corona has enabled the localization of drug carriers in specific tissues such as liver and heart, thus regulating biodistribution. Tailored albumin-NP conjugates have also enabled controlled degradation of NP and drug release. However, the binding of albumin with NP is associated with conformational and functional modulations in protein as observed with silver, gold and superparamagnetic iron oxide NPs. In this review, we highlight the various potential albumin-NP hybrids as nano drug carriers.

<i>Stachytarpheta cayennensis</i> Aqueous Extract, a New Bioreactor towards Silver Nanoparticles for Biomedical Applications

“…A complex is formed which is usually isolated by centrifugation. In that reaction albumin is the reducing agent and a stabilizer [43]. The study of the impact of nanoparticles on protein aggregation is an area of considerable research considering their use as anti-inflammatory or anti-neurodegeneratives agents.…”

Surface modification of polymer nanoparticles with native albumin for enhancing drug delivery to solid tumors

“…Polymeric NPs can be coated with albumin by various methods [19]. The most common approach is to incubate NPs with albumin and let the protein physically adsorb to the NP surface (physisorption) [10, 20].…”

A Safe‐by‐Design Strategy towards Safer Nanomaterials in Nanomedicines

“…Moreover, it has been reported that PEG‐based coatings may introduce other problems such as nondegradation and hypersensitivity . Possible alternatives to PEG include synthetic polymers such as polyoxazolin, polyvinyl pyrrolidone, polyacrylamide, zwitterions, and their block copolymers, natural polysaccharides such as dextran, chitosan, hyaluronic acid, and heparin, biomolecules such as polyaminoacids, albumin, and biomembrane, as well as siliconate treatment . Biodegradable polymers including chitosan, poly(phosphoester) and polyglutamic acid have achieved great attention for medical applications since they could be enzymatically hydrolyzed and degraded into nontoxic small molecules and do not accumulate in the body .…”